Kymera Therapeutics to Present Data on Novel IRAKIMiD and STAT3 Protein Degraders at Virtual 62nd American Society of Hematology (ASH) Annual Meeting

NEXT STORY
Genmab Announces Data to be Presented at 2020 ASH Annual Meeting
PREV STORY
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights

Q1 Cash Balance of $88.4 Million—Cash through Q3 2019 First patient expected to be ...

author_avatar
NASDAQ Market News

Global Airway Management Devices Market 2016-2024: Product Segments (Infraglottic Devices, Resuscitators, Supraglottic Devices) & Applications (Emergency Medicine, Anesthesia)

Dublin, Aug. 16, 2018 (GLOBE NEWSWIRE) -- The "Airway Management Devices - Global Strategic ...

author_avatar
NASDAQ Market News

AIT Therapeutics Announces Publication of Its Phase 2 Trial in Bronchiolitis Patients in the Pediatric Pulmonology Journal

NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage ...

author_avatar
NASDAQ Market News